Pune, India -- (SBWire) -- 03/02/2018 --The Artificial Pancreas Systems Market accounted to USD 80.2 million in 2016 growing at a CAGR of 7.8% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Artificial Pancreas Systems Market Definition:
Artificial pancreas system is a technology which manages the sugar level in blood, reduces T1D-related risks. The system monitors the glucose level in blood and provides substitute endocrine functionality of pancreas.
Request for Free Sample Copy @ http://bit.ly/2oyqHz4
Major Market Drivers and Restraints:
- Government initiatives in clinical research
- Increasing demand of remote monitoring applications
- Increasing demand of home care setting devices
- Longer duration of time to completely absorb insulin
- High initial costs for installing the equipments
- Lack of knowledge and skilled professionals
Artificial Pancreas Systems Market Segmentation:
By devices the market for artificial pancreas systems is segmented into threshold suspend device system, non-threshold suspend device system, control to range system, control to target system,
On the basis of end-users the artificial pancreas systems market is segmented into hospital, clinics, home care, and ambulatory center.
On the basis of geography, artificial pancreas systems market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Inquire before Buying @ http://bit.ly/2oFAlPn
Artificial Pancreas Systems Market Competitive Analysis:
The artificial pancreas systems market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of artificial pancreas systems market for global, Europe, North America, Asia Pacific and South America.
Artificial Pancreas Systems Market Major Market Competitors:
Some of the major players operating in artificial pancreas systems market are Medtronic, Johnson & Johnson, Insulet, Tandem Diabetes Care, Roche, Pancreum, Inc., TypeZero Technologies, LLC, Beta Bionics, Dexcom Inc., Bigfoot Biomedical among others.
Artificial Pancreas Systems Market Research Methodology:
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or drop down your inquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Know more about our Knowledge Store @ http://bit.ly/2F1f6md
Artificial Pancreas Systems Market Analysis, Demand, Application and Global Industry Forecast 2017-2024
Global Artificial Pancreas Systems Market By Device (Threshold suspend device system, Non-threshold suspend device system, Control to range system, Control to target system)